Advanced Nanotheranostics: Evolving Strategies in Cancer Therapy and Diagnosis

The review article delves into the emerging field of nanotheranostics, which synergistically combines therapeutic and diagnostic applications to fight cancer more effectively. With an aim to monitor treatment response, enhance drug efficacy, and ensure patient safety, nanotheranostics represents a cutting-edge frontier in personalized medicine. This review examines the most recent progress in cancer imaging and diagnosis, discussing the use of innovative molecular imaging techniques. It emphasizes the development of various nanotheranostic agents, including gold nanoparticles, silica, liposomes, dendrimers, and other metal-based agents, and their respective targeting mechanisms for tumor cells. Importantly, the article sheds light on the complexities in targeting and delivering therapeutic agents to the correct site of action, highlighting multifunctional and hybrid nanoparticle systems as particularly potent tools in the early detection and treatment of cancer. The review also discusses the specific interactions of nanosystems with cancer cells, touching upon the crucial aspects of receptor binding and nanosystem internalization. Challenges such as the intricate and sometimes unclear mechanisms of nanoparticles, their biodistribution, and their potential hazardous behavior are discussed as critical concerns that need to be addressed for nanotheranostics to reach its full potential in clinical settings. The present review underscores the transformative promise of nanotheranostics in cancer care, advocating for its advancement towards meaningful clinical applications.